SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Sionna Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.01+0.12 (+3.08%)
Close on Oct 19, 2026
- Market cap
- $181.05M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$88.98MFY2025